A Clinical Study on the Improvement of Sleep Quality, Skin Condition and Life Status After Taking Sleep Aid Drinks

June 8, 2023 updated by: Botanee Group Co., Ltd.

The main objective of the study is to observe changes in the subjects' sleep quality, skin condition and life status after 4 weeks of using a sleep aid drink (AOXMED Poria γ-aminobutyric acid drink).

This is a single-center, randomized, double-blind, controlled, 4-week (28-day) clinical study conducted in Chinese healthy women aged 25-55 years old who were offered a sleep aid drink.

Study Overview

Detailed Description

The study population is 70 healthy Chinese women aged 25-55 years with a PSQI ≥ 7 (presence of sleep disorder) who report current problems with dryness, roughness, dullness and lack of elasticity on their face. The subjects will be randomly divided into an experimental group and a control product group of 35 subjects each, and the distribution of age and total hours of sleep will be more or less equal in both groups.

Subjects will be formally enrolled after on-site assessment and will undergo follow-up site visits and test product administration. During the test cycle, subjects in the experimental group will take a drink with the active ingredients of Poria, Poria and GABA, and subjects in the control product group will take a control drink without Poria, Date Palm and GABA ingredients for 4 weeks. To avoid the influence of different skincare products on the results, all subjects will be asked to use the basic skincare products with only moisturizing ingredients provided by the sponsor during the test period. The efficacy of the test products will be verified by comparing the changes in sleep quality, skin condition and life status of the subjects before and after taking the test products for 2 and 4 weeks, and by comparing the differences in sleep quality, skin condition and life status between the test and control groups.

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200000
        • Shanghai China-norm Quality Technical Service Co ,Ltd

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. 25-55 years old, Chinese female;
  2. PSQI index ≥ 7 (presence of sleep disorders);
  3. The subject's self-reported facial problems such as dryness, roughness, dullness, and lack of elasticity;
  4. The BMI of the subjects was between 18~24kg/m2;
  5. After the doctor's clinical evaluation, there are mild facial skin roughness (1 point and above) and mild to moderate overall facial wrinkles (3~6 points);
  6. Corneometer base measurement of facial skin moisture in 15~45 (Corneometer Unit, C.U.) Between;
  7. Have basic Chinese reading ability;
  8. can use smartphones;
  9. Be in good health and free of any other chronic diseases other than skin problems and sleep disorders or diseases being treated;
  10. Voluntarily participate in the test and sign the informed consent form; 11) Willingness to comply with all evaluation requirements;

Exclusion Criteria:

  1. Products with anti-wrinkle, firming, repairing and nourishing effects are not included in the skin care products used;
  2. Intend to become pregnant, or are pregnant or breastfeeding;
  3. Have a history of alcoholism;
  4. Have a history of allergies;
  5. Participated in any clinical trial evaluation within 1 month;
  6. Those who have applied any anti-inflammatory drugs to the test site within the past two months;
  7. Those who have suffered from skin diseases (such as psoriasis, eczema, psoriasis, skin cancer, etc.);
  8. patients with insulin-dependent diabetes;
  9. Patients with asthma or other chronic respiratory diseases who are being treated;
  10. Have taken/injected anti-allergic drugs in the past 1 month;
  11. Patients who have received anti-cancer chemotherapy or immunotherapy patients within the past 6 months;
  12. Have any other health problems or chronic diseases;
  13. Applying retinoids, A hydroxy acids, salicylic acids, hydroquinone within the past 3 months, or prescription drugs (antibiotics, retinoids, A hydroxy acids and steroids) in use within the past 6 months, oral contraceptives (if you have been taking the same contraceptive pills for the past 6 months, you can continue to take them);
  14. Experts or professionals believe that there are other iatrogenic reasons that will affect the evaluation results; 15) Those who have undergone surgery, plastic surgery or organ transplantation in the past year.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
Take drinks with active ingredients such as poria and GABA. Drink half an hour before bedtime, 10ml/bag/day, daily.
Take drinks half an hour before bedtime, 10ml/bag/day, daily. Subjects are uniformly using skin care products provided by the sponsor during the test.
Placebo Comparator: Control product group
Take a control drink that does not contain GABA and poria. Drink half an hour before bedtime, 10ml/bag/day, daily.
Take drinks half an hour before bedtime, 10ml/bag/day, daily. Subjects are uniformly using skin care products provided by the sponsor during the test.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in the Pittsburgh Sleep Quality Index
Time Frame: Week0(Baseline)、Week2、Week4
Obtain change from Baseline PSQI index at 2 weeks by questionnaire. Obtain change from Baseline PSQI index at 4 weeks by questionnaire.
Week0(Baseline)、Week2、Week4
Changes in the sleep duration
Time Frame: Week0(Baseline)、Week2、Week4

Obtain change from Baseline sleep duration at 2 weeks by sleep quality monitoring bracelet.

Obtain change from Baseline sleep duration at 4 weeks by sleep quality monitoring bracelet.

Week0(Baseline)、Week2、Week4
Sleep Quality Assessment after 2-week application
Time Frame: Week2
Obtain data on agreement with sleep improvement by sleep quality self-assessment questionnaire
Week2
Sleep Quality Assessment after 4-week application
Time Frame: Week4
Obtain data on agreement with sleep improvement by sleep quality self-assessment questionnaire
Week4

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in the skin hydration
Time Frame: Week0(Baseline)、Week2、Week4
Obtain change from Baseline skin hydration at 2 weeks by Corneometer. Obtain change from Baseline skin hydration at 4 weeks by Corneometer.
Week0(Baseline)、Week2、Week4
Changes in the skin glossiness
Time Frame: Week0(Baseline)、Week2、Week4
Obtain change from Baseline skin glossiness at 2 weeks by Glossymeter. Obtain change from Baseline skin glossiness at 4 weeks by Glossymeter.
Week0(Baseline)、Week2、Week4
Changes in the skin firmness
Time Frame: Week0(Baseline)、Week2、Week4
Obtain change from Baseline skin firmness at 2 weeks by cutometer. Obtain change from Baseline skin firmness at 4 weeks by cutometer.
Week0(Baseline)、Week2、Week4
Changes in the skin elasticity
Time Frame: Week0(Baseline)、Week2、Week4
Obtain change from Baseline skin elasticity at 2 weeks by cutometer. Obtain change from Baseline skin elasticity at 4 weeks by cutometer.
Week0(Baseline)、Week2、Week4
Changes in the individual type angle
Time Frame: Week0(Baseline)、Week2、Week4
Obtain change from Baseline Individual type angle at 2 weeks by Colorimeter. Obtain change from Baseline Individual type angle at 4 weeks by Colorimeter.
Week0(Baseline)、Week2、Week4
Changes in the proportion of crow's feet area
Time Frame: Week0(Baseline)、Week2、Week4
Calculate the proportion of crow's feet area by Visia CR images. Obtain change from Baseline proportion of crow's feet area at 2 weeks. Obtain change from Baseline proportion of crow's feet area at 4 weeks.
Week0(Baseline)、Week2、Week4
Changes in the proportion of fine lines under the eye
Time Frame: Week0(Baseline)、Week2、Week4
Calculate the proportion of fine lines under the eye by Visia CR images. Obtain change from Baseline proportion of fine lines under the eye at 2 weeks. Obtain change from Baseline proportion of fine lines under the eye at 4 weeks.
Week0(Baseline)、Week2、Week4
Changes in the degree of wrinkle severity
Time Frame: Week0(Baseline)、Week2、Week4

Obtain change from Baseline degree of wrinkle severity at 2 weeks by Dermatologist evaluation according to Skin Aging ATLAS of Asian Type.

Obtain change from Baseline degree of wrinkle severity at 4 weeks by Dermatologist evaluation according to Skin Aging ATLAS of Asian Type.

Week0(Baseline)、Week2、Week4
Changes in the grade of skin dryness
Time Frame: Week0(Baseline)、Week2、Week4

Obtain change from Baseline grade of skin dryness at 2 weeks by Dermatologist evaluation according to 5-point dryness scale.

Obtain change from Baseline grade of skin dryness at 4 weeks by Dermatologist evaluation according to 5-point dryness scale.

Week0(Baseline)、Week2、Week4
Changes in the CIE RGB of skin tone
Time Frame: Week0(Baseline)、Week2、Week4

Dermatologist use PANTONE SkinTone (Pantone color card) skin color guide to evaluate skin tone grade of subjects. Find the CIE RGB corresponding to the skin tone grade in Pantone ColorManager software and convert it into a color value using the formula for data analysis: CIE RGB = R+G*256+B*256*256.

Calculate the change from Baseline CIE RGB of skin tone at 2 weeks. Calculate the change from Baseline CIE RGB of skin tone at 4 weeks.

Week0(Baseline)、Week2、Week4
Skin condition Assessment after 2-week application
Time Frame: Week2
Obtain data on agreement with skin condition improvement by skin condition self-assessment questionnaire
Week2
Skin condition Assessment after 4-week application
Time Frame: Week4
Obtain data on agreement with skin condition improvement by skin condition self-assessment questionnaire
Week4
Changes in the satisfaction with the quality of life
Time Frame: Week0(Baseline)、Week2、Week4

Obtain change from Baseline satisfaction with the quality of life at 2 weeks accessed by WHOQOL-100 questionnaire.

Obtain change from Baseline satisfaction with the quality of life at 4 weeks accessed by WHOQOL-100 questionnaire.

Week0(Baseline)、Week2、Week4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Song Weiming, Master, Yan Shu Medical Beauty Chain Group

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 9, 2022

Primary Completion (Actual)

August 7, 2022

Study Completion (Actual)

August 7, 2022

Study Registration Dates

First Submitted

May 29, 2023

First Submitted That Met QC Criteria

June 8, 2023

First Posted (Estimated)

June 19, 2023

Study Record Updates

Last Update Posted (Estimated)

June 19, 2023

Last Update Submitted That Met QC Criteria

June 8, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data is used to develop new products, no decision has been made on when to disclose

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Disorder

Clinical Trials on Drinks with active ingredients such as poria and GABA

Subscribe